DexCom DXCM Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $919.1M+51.3% | $607.3M+7.0% | $567.5M-11.8% | $643.3M-38.9% | ||
| $1.22B+20.9% | $1.01B+3.3% | $973.9M+36.5% | $713.3M+38.7% | ||
| $629.1M+15.9% | $542.6M-3.0% | $559.6M+82.5% | $306.7M-14.2% | ||
| $4.03B-6.2% | $4.3B-2.8% | $4.43B+20.6% | $3.67B-0.4% | ||
| $1.56B+16.4% | $1.34B+20.4% | $1.11B+5.4% | $1.06B+31.7% | ||
| $24.2M+6.1% | $22.8M-9.5% | $25.2M-1.9% | $25.7M-3.0% | ||
| $70.8M-31.5% | $103.4M-23.1% | $134.5M-22.4% | $173.3M+450% | ||
| —— | $247.7M— | —— | —— | ||
| $6.34B-2.2% | $6.48B+3.5% | $6.26B+16.2% | $5.39B+9.3% | ||
| $344.3M-0.3% | $345.3M+24.9% | $276.4M+16.2% | $237.9M— | ||
| $16.9M+111% | $8M-56.5% | $18.4M+82.2% | $10.1M+381% | ||
| $2.14B-26.9% | $2.93B+88.4% | $1.56B-15.4% | $1.84B+155% | ||
| $3.59B-18.0% | $4.38B+4.4% | $4.2B+28.7% | $3.26B+12.8% | ||
| $400K0.0% | $400K0.0% | $400K0.0% | $400K0.0% | ||
| $2.43B+52.3% | $1.6B+56.4% | $1.02B+113% | $479.9M+246% | ||
| $2.75B+30.6% | $2.1B+1.6% | $2.07B-3.0% | $2.13B+4.4% | ||
| $6.34B-2.2% | $6.48B+3.5% | $6.26B+16.2% | $5.39B+9.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are DexCom's total assets?
- DexCom (DXCM) holds $6.6B in total assets, down 1.8% year over year.
- How much debt does DexCom have?
- DexCom carries $143.0M in total debt against $3.0B of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does DexCom have?
- DexCom holds $1.1B in cash and equivalents.
- Can DexCom cover its short-term obligations?
- Its current ratio is 1.95 — current assets exceed current liabilities.
- Where does DexCom's balance sheet data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
